Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The retinal photoreceptor and retinal pigment epithelium (RPE) cell lipid membranes are specialized structural components essential for the visual process. Photoreceptor outer segments (POS) are characterized by an exceptionally high concentration of polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA), which provides the high membrane fluidity required for the rapid movement of rhodopsin and other phototransduction proteins (Source: NIH, PubMed). The RPE cell membrane plays a critical role in maintaining retinal health by facilitating the daily phagocytosis of shed POS and managing the transport of nutrients and metabolic waste between the neurosensory retina and the underlying choroid (Source: Wikipedia, PubMed). In pathological conditions such as age-related macular degeneration (AMD) and Stargardt disease, these membranes become the primary site for the accumulation of toxic lipofuscin and bis-retinoids like A2E, which lead to oxidative stress, membrane permeabilization, and eventual cell death (Source: PubChem, PubMed). Therapeutic interventions targeting these membranes often focus on visual cycle modulators that limit the production of toxic lipid precursors or antioxidants that prevent the degradation of the lipid bilayer. Preserving the structural and functional integrity of these membranes is a key strategy in preventing geographic atrophy and maintaining central visual acuity in degenerative retinal diseases (Source: ClinicalTrials.gov).
Modulation of the visual cycle to reduce the formation and accumulation of toxic bis-retinoids (e.g., A2E) within the lipid bilayer, stabilization of membrane fluidity, and protection against lipid peroxidation through antioxidant activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal photoreceptor and retinal pigment epithelium cell lipid membranes.